홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-Propanol → Benzyl 4-[2-(4-fluorophenyl)-3-(pyrimidin-4-yl)imidazo[1,2-a]pyridin-7-yl]-piperidine-1-carboxylate

HRID 33354
인쇄

반응식

HRID 33354 반응식
[CH3:1][N:2](C)/[CH:3]=[CH:4]/[C:5]([C:7]1[N:11]2[CH:12]=[CH:13][C:14]([CH:16]3[CH2:21][CH2:20][N:19]([C:22]([O:24][CH2:25][C:26]4[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=4)=[O:23])[CH2:18][CH2:17]3)=[CH:15][C:10]2=[N:9][C:8]=1[C:32]1[CH:37]=[CH:36][C:35]([F:38])=[CH:34][CH:33]=1)=O.C(O)CC.Cl.C(N)=[NH:46].C[O-].[Na+]>CO.C(Cl)Cl>[F:38][C:35]1[CH:36]=[CH:37][C:32]([C:8]2[N:9]=[C:10]3[CH:15]=[C:14]([CH:16]4[CH2:21][CH2:20][N:19]([C:22]([O:24][CH2:25][C:26]5[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=5)=[O:23])[CH2:18][CH2:17]4)[CH:13]=[CH:12][N:11]3[C:7]=2[C:5]2[CH:4]=[CH:3][N:2]=[CH:1][N:46]=2)=[CH:33][CH:34]=1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 10311-PropanolHCID 10313058Methanimidamide, hydrochloride (1:1)HCID 10942334Sodium MethoxideHCID 58774429Benzyl 4-{3-[(2E)-3-(dimethylamino)prop-2-enoyl]-2-(4-fluorophenyl)imidazo-[1,2-a]pyridin-7-yl}piperidin-1-carboxylate

생성물 1

HCID 69210573Benzyl 4-[2-(4-fluorophenyl)-3-(pyrimidin-4-yl)imidazo[1,2-a]pyridin-7-yl]-piperidine-1-carboxylate
수율 66%

시약·촉매·용매 2

HCID 887Methanol용매HCID 6344Dichloromethane용매

반응 조건

온도
100 °C

실험 절차

Benzyl 4-{3-[(2E)-3-(dimethylamino)prop-2-enoyl]-2-(4-fluorophenyl)imidazo-[1,2-a]pyridin-7-yl}piperidin-1-carboxylate (Example 1, Step 5, 0.570 mmol, 300 mg) was charged with 1-propanol (5 mL), formamidine HCl (2.28 mmol, 183 mg), and sodium methoxide (2.28 mmol, 0.521 mL of a 25% w/w solution in methanol). This reaction was heated to 100° C. for 12 hours. The reaction was then poured into a separatory funnel, diluted with methylene chloride (100 mL), washed with 50 mL saturated aqueous NaHCO3 solution, dried over Na2SO4, filtered, concentrated under reduced pressure, then dissolved in a minimum volume of methylene chloride and injected onto an Isco RediSep 40 g normal phase cartridge, and eluted with a gradient that started with 100% heptane and ended with 100% ethyl acetate. Fractions containing desired product were pooled and concentrated under reduced pressure to provide benzyl 4-[2-(4-fluorophenyl)-3-(pyrimidin-4-yl)imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate (191 mg, 66%). MS (ESI+) 508.4. Step 2. Benzyl 4-[2-(4-fluorophenyl)-3-(pyrimidin-4-yl)imidazo[1,2-a]pyridin-7-yl]-piperidine-1-carboxylate (Step 1, 0.368 mmol, 187 mg) was diluted with acetonitrile, then charged with thiophenol (0.553 mmol, 61 mg, 57 μL), and iodotrimethylsilane (3.68 mmol, 737 mg, 524 μL), and the reaction stirred at room temperature for 12 hours. The reaction was concentrated under reduced pressure, then dissolved in a minimum volume of methylene chloride and injected onto an Isco RediSep 40 g normal phase cartridge, and eluted with a gradient that started with 100% methylene chloride and ended with 100% 90:9:1 methylene chloride:methanol:concentrated ammonium hydroxide. Fractions containing desired product were pooled and concentrated under reduced pressure to provide 2-(4-fluorophenyl)-3-(pyrimidin-4-yl)-7-piperidin-4-ylimidazo[1,2-a]pyridine (130 mg, 94%). MS (ESI+) 374.3. Step 3. 2-(4-fluorophenyl)-3-(pyrimidin-4-yl)-7-piperidin-4-ylimidazo[1,2-a]pyridine (Step 2, 0.348 mmol, 130 mg) was diluted in methanol (5.0 mL), then charged with acetic acid (130 μL), 37% w/w formaldehyde in water (0.383 mmol, 31 mg, 29 μL), and NaBH3CN (0.418 mmol, 418 μL of a 1.0M solution in THF). After stirring at room temperature for 30 minutes, the reaction was quenched with 1.0 mL concentrated ammonium hydroxide, then purified via 6×1.0 mL injections onto a reverse phase HPLC column using a gradient that started with 50% methanol:50% 0.1% Et3N in water and ended with 100% methanol. Fractions containing desired product were pooled and concentrated under reduced pressure to provide the title compound (96 mg, 71%). 1H NMR (400 MH, CDCl3) δ 1.91 (m, 4H), 2.10 (m, 2H), 2.35 (s, 3H), 2.59 (m, 1H), 3.02 (m, 2H), 6.89 (dd, J=7.3, 1.9 Hz, 1H), 7.14 (m, 3H), 7.58 (s, 1H), 7.60 (m, 2H), 8.45 (d, 3=5.5 Hz, 1H), 9.25 (s, 1H), 9.65 (dd, J=7.3, 0.7 Hz, 1H). MS (ESI+) 388.3.

후처리

  1. additionThe reaction was then poured into a separatory funnel
  2. washwashed with 50 mL saturated aqueous NaHCO3 solution
  3. dry with materialdried over Na2SO4
  4. filtrationfiltered
  5. concentrationconcentrated under reduced pressure
  6. dissolutiondissolved in a minimum volume of methylene chloride
  7. washeluted with a gradient that
  8. additionFractions containing desired product
  9. concentrationconcentrated under reduced pressure

출처 및 근거

ORD 기록
ord-f931eac0dc0043f79884951579eda421
출처 데이터셋
uspto-grants-2008_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07429590B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트